Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism
- PMID: 23550044
- PMCID: PMC3579408
- DOI: 10.2147/CEG.S39358
Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism
Abstract
Liver dysfunction in patients with hyperthyroidism includes abnormalities associated with the effects of thyroid hormone excess, those secondary to drug-induced liver injury, and changes resulting from concomitant liver disease. Our goal was to describe clinical, biochemical, and histopathological patterns in patients suffering from hyperthyroidism and concomitant liver dysfunction and to propose an algorithm of procedures to facilitate diagnosis and management of such cases. This study describes seven patients with liver biochemistry abnormalities detected after diagnosis of hyperthyroidism and one with undiagnosed decompensated hyperthyroidism and acute hepatitis. Two patients showed autoantibody reactivity which, together with liver histology, suggested the diagnosis of classic autoimmune hepatitis. Three patients experienced hepatotoxicity induced by propylthiouracil, the manifestations of which ranged from a benign course after drug withdrawal in one, a longstanding course in another suggesting drug-induced autoimmune hepatitis, and a more severe clinical condition with acute liver failure in a third patient, requiring liver transplantation. The three remaining patients showed no precipitating factors other than thyroid hyperactivity itself. They could be interpreted as having a thyroid storm with different clinical presentations. In conclusion, this series of patients illustrates the most frequent patterns of hepatocellular damage associated with hyperthyroidism and provides an algorithm for their diagnosis and treatment.
Keywords: autoimmune hepatitis; drug-induced hepatitis; liver function tests; thyroid disease; thyrotoxicosis hepatitis.
Figures




Similar articles
-
Liver Dysfunction in Hyperthyroidism.Hepat Med. 2024 Nov 8;16:81-89. doi: 10.2147/HMER.S487794. eCollection 2024. Hepat Med. 2024. PMID: 39534784 Free PMC article.
-
[The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].Zhonghua Nei Ke Za Zhi. 2004 Jun;43(6):442-6. Zhonghua Nei Ke Za Zhi. 2004. PMID: 15312442 Chinese.
-
The interplay between thyroid and liver: implications for clinical practice.J Endocrinol Invest. 2020 Jul;43(7):885-899. doi: 10.1007/s40618-020-01208-6. Epub 2020 Mar 12. J Endocrinol Invest. 2020. PMID: 32166702 Review.
-
The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.Am J Gastroenterol. 2001 Jan;96(1):165-9. doi: 10.1111/j.1572-0241.2001.03469.x. Am J Gastroenterol. 2001. PMID: 11197248
-
Liver abnormalities and endocrine diseases.Best Pract Res Clin Gastroenterol. 2013 Aug;27(4):553-63. doi: 10.1016/j.bpg.2013.06.014. Best Pract Res Clin Gastroenterol. 2013. PMID: 24090942 Review.
Cited by
-
Fulminant hepatitis and elevated levels of sIL-2R in thyroid storm.Endocrinol Diabetes Metab Case Rep. 2019 Sep 27;2019:19-0078. doi: 10.1530/EDM-19-0078. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2019. PMID: 31600730 Free PMC article.
-
Clinical-laboratory and ultrasound parallels of changes in the liver and thyroid gland in diffuse toxic goiter.J Med Life. 2022 Jan;15(1):78-88. doi: 10.25122/jml-2021-0291. J Med Life. 2022. PMID: 35186140 Free PMC article.
-
Hyperthyroidism and Liver Dysfunction: A Review of a Common Comorbidity.Clin Med Insights Endocrinol Diabetes. 2022 Feb 7;15:11795514221074672. doi: 10.1177/11795514221074672. eCollection 2022. Clin Med Insights Endocrinol Diabetes. 2022. PMID: 35153522 Free PMC article. Review.
-
The progress of autoimmune hepatitis research and future challenges.Open Med (Wars). 2023 Oct 30;18(1):20230823. doi: 10.1515/med-2023-0823. eCollection 2023. Open Med (Wars). 2023. PMID: 38025543 Free PMC article. Review.
-
Fulminant liver failure associated with delayed identification of thyroid storm due to heterophile antibodies.Clin Diabetes Endocrinol. 2015 Oct;1:12. doi: 10.1186/s40842-015-0012-6. Epub 2015 Oct 1. Clin Diabetes Endocrinol. 2015. PMID: 26491542 Free PMC article.
References
-
- Youssef WI, Mullen KD. The liver in other (nondiabetic) endocrine disorders. Clin Liver Dis. 2002;6:879–889. - PubMed
-
- Kubota S, Amino N, Matsumoto Y, et al. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves’ disease and painless thyroiditis. Thyroid. 2008;18:283–287. - PubMed
-
- Babb RR. Associations between diseases of the thyroid and the liver. Am J Gastroenterol. 1984;79:421–423. - PubMed
-
- Fong TL, McHutchinson JG, Reynolds TB. Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol. 1992;14:240–244. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources